Table 1 Patient characteristics
From: Serum procalcitonin improves diagnosis of infectious complications after CRS/HIPEC
CRS/HIPEC | |
|---|---|
Number of patients | 248 |
Age | 54 (46–63) |
Gender (male/female) | 141(57%)/107(43%) |
Preoperative systemic chemotherapy | 106 (43%) |
Anastomosis (number) | 1 (0–2) |
Complications (Clavien Dindo) | |
none | 145 (59%) |
Grade I | 11 (4%) |
Grade II | 42 (17%) |
Grade IIIa | 22 (9%) |
Grade IIIb | 21 (8%) |
Grade IVa | 4 (2%) |
Grade IVb | 0 |
Grade V | 3 (1%) |
Infectious complications | 61 (25%) |
Superficial | 16/61 (26%) |
Deep | 2/61 (3%) |
Organ space | 43/61 (71%) |